This study is for adults aged 18-75 with advanced colorectal cancer causing malignant ascites (excess fluid in the abdomen). The study tests the safety and effectiveness of a drug called T3011, given directly into the belly. Participants should have a life expectancy of at least three months and meet certain health criteria related to blood counts and organ function.
Key Points:
Note: You must attend regular visits and follow study guidelines. This trial is for those who have tried other treatments without success. Always discuss with your doctor before joining a study to understand potential risks and benefits.
NCT06200376
West China Hospital
24 January 2024
,
You have contacted , on
Your message has been sent to the study team at ,
You are contacting
Primary Contact
Congrats! You have your own personal workspace now.